Our study shows that insulin promotes colon tumor growth, decreases the number of tumoral infiltrated CD8+ T cells, and weakens the therapeutic effect of anti-PD1 on colon tumor growth inhibition. This evidence concerns the gene CD8A and colonic neoplasm.